<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <link rel = "stylesheet" href = "styles.css/style.css">
</head>
<body>
    <h1 id = "QIP">QIP: Switching of Eye Drops</h1>
    <h2><span>Objectives</span></h2>
        <p>
            Switching all adult patients to Eyeaz 0.1% or 0.2% who are prescribed the following: 
            <ul>
                <li>Hylo-Tear 0.1% eye drops</li>
                <li>Hy-Opti 0.1% eye drops</li>
                <li>Xailin Tears HA 0.1% eye drops</li>
                <li>Hylo-Forte 0.2% eye drops</li>
                <li>Hy-Opti 0.2% eye drops</li>
                <li>Clintas Multi 0.2% eye drops</li>
                <li>Evolve HA 0.2% eye drops</li>
                <li>Xailin Plus HA 0.2% eye drops</li>
                <li>HydraMed 0.2% eye drops</li>
            </ul>
        </p>
        <p>Switch applies to 0.1% and 0.2% strengths of the branded generics available. Switching Sodium Hyaluronate 0.15% eye drops, however, reamins the prescriber's clinical decision to switch to either 0.1% or 0.2% product, if clinically appropariate to do so.</p>
    <h2><span>Background</span></h2>
        <p>For patients who have a diagnosis of dry eyes, Sodiium Hyaluronate eye drops, also known as artificial tears, are prescribed. The eye drops are used to relieve dry eyes and soreness, lubricating the surface of the eye to increase comfort.</p>
        <p>As per <a href = "https://cks.nice.org.uk/topics/dry-eye-syndrome/management/management/" target = "_blank">NICE CKS guidance,</a> a prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.</p>
    <h2><span>Cost</span></h2>
        <p>Eyeaze has a lower acquision cost than other generic and branded equivalents; switching all patients across NW London primary care to this preferred branded generic could potentially save an estimated £280,000.</p>
        <p>Below is a cost comparison of Eyeaze to other currently prescribed eye drops for a 10ml quantity:</p>
        <ul>
            <li>Eyeaze 0.1% eye drops: £4.15</li>
            <li>Eyeaze 0.2% eye drops: £4.15</li>
            <li>Hylo-Tear 0.1% eye drops: £8.50</li>
            <li>Hy-Opti 0.1% eye drops: £8.50</li>
            <li>Ocu-Lube HA 0.1% eye drops: £8.00</li>
            <li>Hylo-Forte 0.2% eye drops:£9.50</li>
            <li>Hy-Opti 0.2% eye drops: £9.50</li>
            <li>Clintas Multi 0.2% eye drops: £5.99</li>
            <li>Evovle HA 0.2% eye drops: £5.99</li>
            <li>Xailin Plus HA 0.2% eye drops: £5.60</li>
            <li>Xailin HA 0.2%: £7.44</li>
            <li>Ocu-Lube HA 0.2% eye drops: £7.90</li>
            <li>HydraMed 0.2%: £5.60</li>
        </ul>
    <h2><span>Actions/Recommendations</span></h2>
        <p>Review patients currently prescribed generic and listed branded generics Sodium Hyaluronate PF eye drops, for suitability for switching to Eyeaze ® 0.1% and 0.2%</p>
        <p> Please see attached pdf for further considerations for cauton and exclusion with regard to patient sensitivites.</p>
</body>
</html>

